Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMILe
NCT06349668Phase 3Recruiting
- Start
- Apr 2024
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of morphine, bupivacaine hydrochloride 0.75% injection in postoperative pain. Started Apr 2024; status: recruiting.
02
Drugs
morphinebupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06349668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06349668.